Africa CDC sends Ebola experts to investigate Nigeria's first case in over a decade
Africa CDC sent Ebola experts to investigate Nigeria's first case in over a decade. Merck's sac-TMT ADC reduced risk of death by 33% in advanced endometrial cancer Phase 3 trial. Merck-Moderna mRNA cancer vaccine showed 42% reduction in recurrence or death in melanoma Phase 3 study.